Cancer Drug Development Roundtable at Ohio State

Background Information:

Background Document
Agenda
List of Participants
Bios of Participants
FDA Guidance Document published in the Federal Register

Feb. 2011 Opinion/Editorial from Michael A. Caligiuri, MD from Oncology Times, Feb. 2011

“Development of Rational Drug Combinations with Investigational Targeted Agents” Friends of Cancer Research document

“When it takes two to tango, FDA suggests a new regulatory dance” article from Nature, March 2011, that summarizes the early work on this topic

“Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements” article from Nature Reviews, Nov. 2010